Regulated information

Press releases

20 September 2016  - Paris (France)

Disclosure of transactions in own shares between 12-09-2016 and 16-09-2016

14 September 2016  - Paris (France)

European Commission approves Ipsen’s Cabometyx™ (cabozantinib) Tablets for the treatment of advanced renal cell carcinoma (RCC) in adults following prior vascular endothelial growth factor (VEGF)-targeted therapy

13 September 2016  - Paris (France)

Disclosure of transactions in own shares between 05-09-2016 and 09-09-2016

09 September 2016  - Paris (France)

Information regarding the total number of voting rights and shares

06 September 2016  - Paris (France)

Disclosure of transactions in own shares between 29-08-2016 and 02-09-2016

30 August 2016  - Paris (France)

Disclosure of transactions in own shares between 22-08-2016 and 26-08-2016

23 August 2016  - Paris (France)

Disclosure of transactions in own shares between 15-08-2016 and 19-08-2016

14 August 2016

Disclosure of transactions in own shares between 08-08-2016 and 12-08-2016

05 August 2016  - Paris (France)

Disclosure of transactions in own shares between 01-08-2016 and 05-08-2016

05 August 2016  - Paris (France)

Information regarding the total number of voting rights and shares

Updated on 26 January 2016